During the entry process, the human papillomavirus (HPV) capsid is trafficked to the trans-Golgi network (TGN), whereupon it enters the nucleus during mitosis. We previously demonstrated that the minor capsid protein L2 assumes a transmembranous conformation in the TGN. Here we provide evidence that the incoming viral genome dissociates from the TGN and associates with microtubules after the onset of mitosis. Deposition onto mitotic chromosomes is L2-mediated. Using differential staining of an incoming viral genome by small molecular dyes in selectively permeabilized cells, nuclease protection, and flotation assays, we found that HPV resides in a membrane-bound vesicle until mitosis is completed and the nuclear envelope has reformed. As a result, expression of the incoming viral genome is delayed. Taken together, these data provide evidence that HPV has evolved a unique strategy for delivering the viral genome to the nucleus of dividing cells. Furthermore, it is unlikely that nuclear vesicles are unique to HPV, and thus we may have uncovered a hitherto unrecognized cellular pathway that may be of interest for future cell biological studies.
Incoming human papillomavirus type 16 Edited by Peter M. Howley, Harvard Medical School, Boston, MA, and approved April 26, 2016 (received for review January 13, 2016) During the entry process, the human papillomavirus (HPV) capsid is trafficked to the trans-Golgi network (TGN), whereupon it enters the nucleus during mitosis. We previously demonstrated that the minor capsid protein L2 assumes a transmembranous conformation in the TGN. Here we provide evidence that the incoming viral genome dissociates from the TGN and associates with microtubules after the onset of mitosis. Deposition onto mitotic chromosomes is L2-mediated. Using differential staining of an incoming viral genome by small molecular dyes in selectively permeabilized cells, nuclease protection, and flotation assays, we found that HPV resides in a membrane-bound vesicle until mitosis is completed and the nuclear envelope has reformed. As a result, expression of the incoming viral genome is delayed. Taken together, these data provide evidence that HPV has evolved a unique strategy for delivering the viral genome to the nucleus of dividing cells. Furthermore, it is unlikely that nuclear vesicles are unique to HPV, and thus we may have uncovered a hitherto unrecognized cellular pathway that may be of interest for future cell biological studies.
HPV entry | vesicular transport | mitosis | digitonin | nuclear vesicle A major hurdle of DNA viruses during a primary infection is successful navigation of the cytoplasm to deliver the viral genome to the nucleus. Foreign DNA that enters the cytoplasm is susceptible to being sensed by innate immune sensors (1) . Not surprisingly, viruses have evolved mechanisms to evade detection by these sensors. For example, herpesviruses and adenoviruses both egress into the cytoplasm, yet protect their viral DNA by keeping it encased in viral capsids until directly transferring it into the nucleus through the nuclear pore complex. In contrast, the capsid is unlikely to protect papillomavirus (PV) genomes while traversing the cytoplasm, because the major capsid protein is lost in the endocytic compartment (2) .
The PV capsid is composed of two viral proteins, the major capsid protein L1 and the minor capsid protein L2, which enclose a chromatinized, circular, double-stranded DNA genome ∼8 kb in size (3) (4) (5) (6) . Following primary attachment and internalization, acidification of early endosomes triggers capsid disassembly (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Host cell cyclophilins release the majority of L1 from the L2 protein, which remains in complex with the viral genome (2, 23, 24) . A large portion of the L2 protein translocates across the endocytic membrane to engage factors, including the retromer complex, dynein, sorting nexins, and rab GTPases, that mediate transport to the trans-Golgi network (TGN) (25) (26) (27) (28) (29) (30) (31) (32) (33) ). An siRNA screen has suggested that nuclear pore complexes are not required for nuclear entry, but that nuclear envelope breakdown during mitosis is necessary (34, 35) .
Currently, when and how the human PV (HPV) genome egresses from the membranous compartment is unclear. Here we present evidence indicating that after the onset of mitosis, the viral genome of HPV type 16 (HPV16), an HPV type associated with malignancies (36) , egresses from the TGN and associates with microtubules. The viral genome migrates along microtubules to the condensed chromosomes, facilitated by the L2 protein.
During this time, the viral genome resides in a vesicular compartment, presumably a transport vesicle, until the completion of mitosis, delaying viral gene expression.
Results
Incoming Viral Genome Is Trafficked in Membrane-Bound Vesicles During Mitosis. To study the trafficking of HPV virions, we used efficient generation of pseudoviral particles, which are considered indistinguishable from native virions but encapsidate a reporter plasmid (pseudogenome) (4, 37, 38) . We also generated quasivirions in 293TT cells that encapsidate the HPV16 genome (39) . For most experiments, we used particles containing a pseudogenome labeled with 5-ethynyl-2′-deoxyuridine (EdU), a nucleotide analog that can be detected by immunofluorescent staining using Click-iT chemistry (40) . Using differential permeabilization and epitope-mapped monoclonal antibodies (Fig. 1A) , we recently demonstrated that the L2 protein assumes a transmembranous configuration in the TGN where the putative transmembrane domain (TM; residues 45-65) separates the luminal epitope (residues 18-35) from epitopes located C-terminally of the TM domain and facing the cytosol (32) . In contrast, L1 protein was found exclusively in the luminal compartment of the TGN.
Because the point at which the viral genome egresses from membranous compartments during infectious entry remains unknown, we used the same approach to test for epitope accessibility in mitotic cells using EdU-labeled particles. HaCaT cells were infected with HPV16 pseudovirus for 24 h and then selectively permeabilized using a low concentration of digitonin (DIG) that permeabilizes the plasma membrane and early endosomes but not TGN, Golgi, or endoplasmic reticulum (ER) (32) . We observed that the epitope comprising residues 18-35 as well as L1 was still
Significance
Following egress from the endocytic compartment, nonenveloped DNA viruses have a distinct cytoplasmic phase whereupon the viral genome is transported into the nucleus of infected cells via nuclear pores. In contrast, the human papillomavirus (HPV) waits for nuclear envelope breakdown during mitosis to gain access to the nucleus. Here we provide evidence that the HPV genome resides continuously in a transport vesicle until mitosis is completed. This suggests that membranebound vesicles can temporally exist in the nucleus. Because vesicles are not normally detected in the nucleus, this also points to the existence of an unrecognized cell pathway for the disposal of nuclear vesicles.
inaccessible in cells undergoing mitosis, whereas a downstream epitope (residues 163-170) was accessible ( Fig. 2A) , suggesting that L2 protein is still transmembranous during mitosis.
As reported previously, the L2-specific antibodies show a high level of background even in uninfected cells, along with a low signal intensity (32) . In addition, the antibodies are large macromolecules of ∼150 kDa and have limited accessibility for proteins present in larger complexes. To achieve a higher level of sensitivity and better penetration, we developed an assay using the low-molecular-weight dyes Alexa Fluor (AF) 555 and AF647 (∼ 500 Da), which are not cell-permeable on their own but can readily penetrate cells after DIG treatment, as well as nuclei of DIG-permeabilized cells, through the nuclear pores (Fig. S1C) .
HaCaT cells were infected with HPV16 pseudovirus harboring an EdU-labeled pseudogenome. At 24 h postinfection (hpi), the cells were fixed, and the plasma membrane was selectively permeabilized using a low concentration of DIG. In a first Click-iT reaction, accessible DNA was stained with AF555. Then the cells were completely permeabilized with Triton X-100 (TX-100) and treated with AF647 in a second Click-iT reaction (Fig. 1B) . We observed that the pseudogenome localized within the TGN during interphase was inaccessible to the AF555 dye after DIG treatment (Fig. 2B ). In line with our results presented above, we observed that the pseudogenomes associated with condensed chromosomes at various stages of mitosis were also inaccessible to AF555 after DIG treatment (Fig. 2C) . Only after the completion of mitosis did we observe double-positive staining from both dyes within the nucleus.
We performed several control experiments to demonstrate the usefulness of this approach. First, we observed double-positive staining of pseudogenomes present on the extracellular matrix, supporting the feasibility of sequential staining and the capability of the dyes to penetrate viral capsids (Fig. S1A) . We then tested sequential staining of internalized virions in cells treated with bafilomycin A1 (BafA1) at 18 hpi. BafA1 prevents the trafficking and acidification of early endosomes, as well as the uncoating of HPV16 ( Fig. S1B) (41, 42) . In addition, we observed double-positive staining of cells that had been pulse-labeled with EdU during interphase and all stages of mitosis, suggesting that the plasma membrane can be permeabilized at all stages of the cell cycle under these conditions (Fig. S1C ). Double-positive staining was also observed when DIG was replaced by TX-100 ( Fig. S1 B and C).
We also tested our differential staining assay for enveloped vaccinia virus (VACV), which has a strict cytoplasmic phase during the infection (43) . We observed that the EdU-labeled VACV DNA was inaccessible to AF555 on the cell surface and accessible to both dyes after internalization (Fig. S1 D and E) . Taken together, these data suggest that the incoming HPV genome is inaccessible to small-molecule dyes throughout mitosis, and thus likely resides in a membranous compartment, possibly a transport vesicle.
Incoming Viral Genome Is Protected from Nuclease Digestion During
Mitosis. To support the foregoing findings, we performed biochemical analyses on cells arrested in mitosis. We used the cellpermeable Eg5 inhibitor III (Eg5i) to block Eg5 kinesin, a motor protein required for spindle bipolarity. Inhibition by Eg5i arrests the cells in a monoastral phenotype (44) . Although the HPV entry process is highly asynchronous, we observed that the majority of EdU puncta localized at condensed chromosomes in cells infected with pseudovirions in the presence of Eg5i. When we coupled Eg5i treatment with our differential staining assay, we found that the pseudogenomes were inaccessible to AF555 after DIG treatment, confirming their residence in a membranebound compartment (Fig. 3A) .
We next infected HaCaT and HeLa cells with HPV16 pseudovirus in the presence of Eg5i, mechanically disrupted the plasma membrane, and treated cell extracts with DNase I to digest all accessible DNA molecules. We observed that the majority of the pseudogenomes, but not cellular DNA, was protected from digestion but became susceptible after TX-100 treatment (Fig. 3B ). When we blocked acidification and trafficking of HPV16-containing endocytic vesicles with BafA1, the viral genome was protected to a similar level (41, 42, 45) .
Further support for residence within a vesicular compartment during mitosis came from our flotation assays. At 18 hpi in the presence of Eg5i or BafA1, we generated cell extract from HeLa cells by mechanical disruption. Extracts were layered at the bottom of a sucrose step gradient, and during centrifugation, the HPV16 genome migrated up through the gradient, consistent with an association with lipids. Highly purified quasivirus alone remained near the bottom of the gradient (Fig. 3C) . As a control, we demonstrated flotation of the early endosomal marker EEA1 from cell extract by Western blot analysis (Fig. S2A) . When highly purified quasivirus was combined with cell extract, upward migration of the viral genome to higher fractions was unexpectedly observed. Preincubation of purified quasivirus with soluble heparin abolished this upward migration, suggesting that it was due to an interaction with heparan sulfates present on plasma membrane-derived vesicles (Fig. S2B) . The relative density of DNA was distinct in BafA1-and Eg5i-treated samples, suggesting that the viral DNA resides in vesicles of differing natures.
In contrast to our observations, a previous study reported that inhibition of Eg5 has no effect on pseudoviral infectivity in both HeLa and HaCaT cells (34) . In line with that study, we also observed no significant inhibition of infection in the presence of Eg5i (Fig. S3C) ; however, we found a markedly reduced number of viable cells after 48 h (70.85% ± 3.75; n = 3) (Fig. S3A) , raising the possibility that the GFP + cells had escaped inhibition. To clarify this finding, we repeated the infection and monitored the GFP expression of individual cells using live-cell imaging. We observed that all cells expressing GFP had previously completed at least one round of mitosis (Movies S1 and S2), confirming that some cells can escape Eg5 inhibition. On the other hand, cells arrested in the monoastral phenotype never expressed GFP (Fig.  S3B) . The leakiness of Eg5 inhibition explains the apparent discrepancy of our observations with previously published infectivity data and provides further indirect evidence that the viral genome is retained in a vesicle during mitosis.
Release of the Viral Genome from the Vesicle Is Delayed. We observed that the viral genome remains inaccessible to AF555 dye in cells permeabilized with DIG in a minority of interphase cells ( Fig. 4A) , suggesting delayed egress from the putative transport vesicle. In controls, we observed dual staining with AF555 and AF647 in the TX-100-treated cells (Fig. S4A) . To estimate the time it takes for the viral genome to become accessible after cytokinesis, we measured the number of nucleoli. In early G1 phase, a large number of smaller prenucleolar bodies are present that assemble to form the smaller number of larger nucleoli. In HeLa cells, this process takes ∼2 h after telophase (46, 47) . Accessibility of the viral genome to AF555 after DIG treatment was inversely correlated with the number of nucleolar bodies observed (Fig. 4B and Fig. S4B ).
To test whether delayed release is correlated with delayed GFP expression, we used the MATra transfection method, which requires mitosis for the DNA to enter the nucleus. We found that expression of the same marker plasmid delivered by HPV16 particles was delayed by ∼4 h compared with delivery by transfection (Fig. 4 C and D and Movies S3 and S4). Taken together, these data suggest that release from the vesicle is delayed after the completion of mitosis.
L2 Mediates Transport Along Microtubules During Mitosis. L2 protein has been demonstrated to interact with components of the dynein motor protein complex, opening up the possibility that viruscontaining transport vesicles also use microtubule-mediated transport during mitosis (30, 31) . Indeed, we found the incoming viral genome in close proximity to astral microtubules located between the TGN and the microtubule-organizing center (MTOC) in prophase and prometaphase cells. During metaphase, we observed the viral genome next to spindle microtubules and/or the condensed chromosomes. In telophase cells, the viral genome was retained in the newly formed nuclei of dividing cells (Fig. 5A) .
We next asked whether the L2 protein is facilitating this transport. Our group and others have previously characterized several point mutations within the nuclear retention region of the L2 protein that are important for nuclear delivery of the viral genome (23, 48) . EdU-labeled pseudovirus harboring mutant L2 protein (R302/5A) has been associated with astral microtubules in prophase and prometaphase like WT; however, despite infecting cells with similar amounts of visible EdU-labeled particles per cell (Fig. 5B) , we found a dramatic loss of the viral genome associated with the condensed chromosomes during later stages of mitosis (Fig. 5C ). By telophase, we observed a nearly complete loss of the viral genome from the nuclei of dividing cells in pseudovirus harboring the mutant L2 protein. Taken together, these data suggest that the viral genome dissociates from the TGN and transports along microtubules, and that L2 protein facilitates an association with condensed chromosomes.
Discussion
Here we have demonstrated that HPV resides and traffics in a vesicle throughout mitosis. Our conclusions are based on our findings that the viral genome is inaccessible to small-molecule dyes during all stages of mitosis, is protected from nuclease digestion, has low buoyant density in flotation gradients, displays delayed expression, and associates with microtubules during mitosis. Moreover, luminal epitopes of capsid proteins are inaccessible to antibodies during mitosis. Dye accessibility and delayed expression kinetics suggest that release from the putative transport vesicle inside the nucleus occurs after completion of mitosis and reestablishment of the nuclear envelope.
Our observations are somewhat contradictory to recently published findings purporting that arresting cells in a monoastral phenotype does not block HPV16 infection (34) . However, a careful analysis reveals that Eg5 inhibition is leaky and that a minority of cells complete an additional cell cycle rather than being arrested in mitosis. Live-cell imaging demonstrated that only cells completing mitosis, and not those directly arrested in the monoastral phenotype, express GFP protein encoded by the Fig. 2 . Incoming viral genome resides in a vesicle until the completion of mitosis. (A) At 24 hpi with EdU-labeled pseudovirus, HaCaT cells were fixed, permeabilized with 5 μg/mL of DIG or 0.5% TX-100, and incubated with primary L2-specific antibodies K4 (amino acids 20-38), 33L2-1 (amino acids 163-170), or L1-specific antibody 33L1-7 (amino acids 303-313), followed by a subsequent secondary antibody (green). Cells were fixed again, permeabilized with 0.5% TX-100, and treated with AF555 (red) in Click-iT reaction buffer. The nucleus was stained with DAPI (white). A luminal epitope of TGN46 (blue) served as a control to assess intracellular membrane integrity. Note the lack of reactivity of both the K4 and 33L1-7 antibodies in DIG-treated cells. (B) HaCaT cells were infected as described above. At 24 hpi, cells were fixed, permeabilized in 0.625 μg/mL DIG or 0.5% TX-100, and treated with AF555 (green) in Click-iT reaction buffer. Cells were fixed again, permeabilized with 0.5% TX-100, and treated with AF647 (red). TGN46 (blue) was stained after TX-100 treatment. The nucleus was stained with DAPI (white). (C) HaCaT cells were infected and differentially stained as described in B. A luminal epitope of TGN46 (white) served as a control to assess intracellular membrane integrity. Note the absence of AF555 staining in pseudogenomes localized to the TGN and associated with mitotic chromosomes. pseudogenome. Cells that were directly arrested in mitosis died within the 48 h incubation period and were discarded during flow cytometry, giving the wrong impression that these inhibitors do not block infection. The prolonged treatment with inhibitors of mitosis without expression in arrested cells and nuclease resistance suggests that membranous structures protecting the viral genome are rather stable during mitosis. Currently, we are unable to determine whether the viral genome is present within an HPV-induced transport vesicle or HPV is usurping a preexisting cellular pathway. Regardless, our data suggest that the L2 protein is important for directing the HPV-containing membranous structures toward the nucleus during mitosis. It was recently demonstrated that the L2 protein becomes transmembranous to engage numerous cytoplasmic factors required for trafficking to the TGN and possibly the ER, with some 30 N-terminal residues being luminal (28, 32) . We have shown that L2 assumes a similar topography during mitosis, suggesting that HPV-harboring vesicles bud out of the TGN or the ER during the onset of mitosis. During cell division, the TGN and ER undergo reorganization and fragment into vesicles (49) . This partitioning of the TGN and ER ensures that both compartments are equally distributed to the newly formed daughter cells. Therefore, it can be speculated that HPV takes advantage of this reorganization event to hijack a vesicle by using putative L2 interaction domains present on the cytosolic side of the membrane.
We also provide evidence that HPV-harboring vesicles traffic along microtubules. Initially, this seems to be a minus end-directed transport toward the MTOC. One possibility is that HPV uses dynein, which is known to bind to L2 protein, to facilitate trafficking (30, 31) . Based on the association of HPV-harboring vesicles with spindle microtubules at later mitotic stages, we speculate that HPV migrates in a minus end-directed fashion along astral microtubules from the TGN to the MTOC. This is followed by plus end-directed transport along spindle microtubules from the spindle pole to condensed chromosomes, thus pointing to a switch in directionality. To date, however, live-cell imaging of late trafficking of HPV particles has been unsuccessful, precluding us from directly testing this idea. Fig. 3 . Vesicle protects the incoming viral genome from digestion during mitosis. (A) HaCaT cells were infected in the presence of Eg5i and differentially stained as described in Fig. 2 B and C. Note the absence of AF555 staining in pseudogenomes associated with arrested cells. (B) HaCaT and HeLa cells were infected with HPV16 pseudovirus for 24 h and 18 h, respectively, in the presence of 1.5 μM Eg5i or 0.5 μM BafA1. Monoastral phenotypic cells were isolated from the bulk population of Eg5i-treated cells, whereas total cells were collected in the BafA1 treatment. Note that BafA1 treatment blocks acidification and capsid uncoating. Plasma membranes were mechanically disrupted, and the cell lysates were treated with 10 U of DNase I for 3 h in the presence or absence of TX-100. Total DNA was isolated and analyzed by real-time quantitative PCR (qPCR). Data are reported as -Δ Ct normalized to DNA isolated from TX-100-treated samples. Note that the HPV16 genome is protected from DNase I digestion up to 6.99 ± 0.23 and 7.02 ± 0.18 Ct values in HaCaT and HeLa cells, respectively (n = 3). (C) HeLa cells were infected with HPV16 quasivirions encapsidating an HPV16 genome for 24 h in the presence of 1.5 μM Eg5i or 1 μM BafA1. Cells were collected and mechanically disrupted as described in B. Cell lysates were fractionated using a sucrose density gradient. DNA in the gradient fractions was amplified using HPV16 E6-specific primers by conventional PCR using dilutions of the gradient fractions as a template and visualized by gel electrophoresis. Purified HPV16 quasivirus was fractionated as a virus-only control. Note that the HPV16 genome is enriched in fraction 4 in the Eg5i-treated cells, whereas it is enriched in fraction 6 in BafA1-treated cells. Fig. 4 . Release of the viral genome from the vesicle is delayed. (A) HaCaT cells were infected as described in Fig. 2 B and C. LBR (white) was stained after TX-100 treatment. Note the absence of AF555 staining within the nuclei of the DIG-treated cells in cytokinesis and some interphase cells. (B) Quantification of the AF555 accessibility as a percentage of total AF647 relative to the number of individual puncta per cell. The total number of nucleoli per cell was counted as well (∼50 cells counted per biological replicate, n = 3; mitotic, P < 0.0005; 7+ nucleoli, P < 0.0001; 5-6 nucleoli, P < 0.005; 1-4 nucleoli, P = 0.0303). Note that increased accessibility is inversely correlated with the number of nucleoli present per image slice. (C and D) HeLa cells were infected with HPV16 pseudovirus encapsidating pseudogenomes or transfected using MATra with pfwB plasmid for 72 h. Live-cell images were obtained once an hour. Cells were quantified by counting how long it took cells to display GFP expression following the onset of mitosis (50 cells counted per biological replicate, n = 3; P < 0.005). (D) Time lapse of HeLa cells from the onset of mitosis until display of GFP expression after delivery of pfwB by HPV16 pseudovirus and transfection with MATra reagent, respectively. Expression levels of GFP in the infection reached comparable levels to those of the transfection over time (Movie S3).
Previous observations have suggested that L2 protein can associate with condensed chromosomes during mitosis (34) ; therefore, it is reasonable to speculate that L2 may interact directly with nuclear resident proteins or with the condensed chromosomes to ensure that the transport vesicle remains associated with the mitotic bodies until the completion of mitosis. We have provided evidence that the 16L2-R302/5A mutant protein is defective for deposition of HPV-harboring vesicles on condensed chromosomes. This would suggest that the mutation disrupts interactions with nuclear components. Indeed, the mutation disrupts the nuclear retention of overexpressed L2 (48) . It is also conceivable that this mutant is incapable of plus end-directed transport, however. We previously reported that this mutation resulted in increased levels of viral genome in the TGN of interphase cells (23) , and suggested that 16L2-R302/5A is defective for mediating egress from the TGN; however, given our finding of dissociation from the TGN in prophase, an alternative explanation for the phenotype of this mutant protein may be a lack of interaction with motor proteins mediating plus end-directed transport, such as kinesins. It may be speculated that the deficiency in kinesin interaction speeds up net minus enddirected transport, resulting in increased levels of viral genome at the TGN. Further studies are needed to address this idea.
The L2 protein inserts into the membrane shortly after internalization and uncoating to facilitate intracellular trafficking. Our data demonstrate that this is not sufficient to release the genome into the cytoplasm, suggesting the need for cellular factors not present in the endocytic compartment, including TGN and ER. In that regard, HPV16 is unlike adenovirus, which uses the viral protein VI to rupture the endocytic membranes (50) . On the other hand, polyomaviruses take advantage of the ER-associated degradation system to translocate across the ER membrane (51, 52) . Because HPV delays its release until after mitosis and nuclear envelope reformation, it is unlikely to use similar mechanisms. Given this delayed timing, we can assume that the HPV-harboring vesicles are not involved in early events of nuclear envelope reformation and might not fuse with the nuclear envelope, which would deliver the viral genome into the nuclear intermembrane space rather than to the nucleoplasm. There is no published evidence for the existence of intranuclear vesicles; as such, it is tempting to speculate that degradation pathways may exist to remove vesicles fortuitously ending up in the nucleus during mitosis. Indeed, a number of nuclear phospholipases are involved in the turnover of lipids, although their exact function inside the nucleus is not well understood (53) .
Interestingly, siRNA screens have identified several phospholipases required for HPV infection (27, 34) . Another nonenveloped virus, parvovirus, uses phospholipases to penetrate intracellular membranes. On entry into the endosome, low pH triggers the parvovirus virion to deploy a lipolytic enzyme, phospholipase A 2 , expressed on the N terminus of VP1, the minor coat protein, to egress into the cytoplasm (54) . Considering that the HPV capsid proteins have no known enzymatic activity, it may be speculated that HPV instead takes advantage of cellular phospholipases for egress. A release based on degradation would be consistent with the observed time delay. The study of HPV genome release might provide insight into the host cell factors involved in related cellular processes.
Furthermore, viruses often usurp existing cellular pathways, and it is unlikely that the observed nuclear vesicles are HPV-specific. Thus, we may have uncovered a hitherto unrecognized pathway for delivering cargo to the nucleus. Clearly, more research is needed to fully understand the late trafficking events and egress of HPV and to explore the host cell factors essential for these events.
Materials and Methods
The LSU Health Shreveport's Institutional Biosafety Committee approved all of the experiments reported herein (project no. B06-009; approval of update on December 10, 2015).
Immunofluorescent Microscopy Using Click-iT Reaction Chemistry After Selective Permeabilization. HaCaT cells were grown on coverslips for 24 h to ∼50% confluency and infected with HPV16 pseudovirus encapsidating the EdUlabeled pseudogenome at ∼200-500 EdU puncta per cell in the presence or absence of inhibitors. After specified times after infection, the cells were fixed with 4% (wt/vol) paraformaldehyde (PFA) for 15 min at room temperature (RT), washed with PBS, and selectively permeabilized with 0.625 μg/mL of DIG in PBS for 10 min at RT. The cells were washed in PBS and blocked in 5% (wt/vol) normal goat serum (NGS) for 30 min. Cells were treated with the first round of AF555 in Click-iT reaction buffer for 30 min at RT protected from light. After washing in PBS, an optional incubation for 1 h with primary rabbit polyclonal antibody anti-TGN46 in 2.5% NGS at 37°C was performed, followed by extensive washing with PBS and incubation with a secondary polyclonal antibody, goat anti-rabbit conjugated with AF488 in 2.5% NGS for 1 h at 37°C. Cells were washed extensively once more in PBS and fixed in 1% PFA for 5 min at RT. Cells were washed again in PBS and permeabilized using 0.5% TX-100 for 10 min at RT. After an extensive wash with PBS, cells were treated with a second round with AF647 in Click-iT reaction buffer for 30 min at RT protected from light. Cells were then washed extensively again in PBS, and an optional second round of primary and secondary antibody was used to detect Lamin B receptor (LBR), Laminin 33, or TGN46 in 2.5% NGS for 1 h each at 37°C. Finally, the cells were washed in PBS and mounted with DAPI. Single slice images and Z-stacks were acquired with a Leica TCS SP5 spectral confocal microscope. All images from each individual experiment were acquired under the same laser power settings and enhanced uniformly in Adobe Photoshop and/or ImageJ.
